These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
684 related articles for article (PubMed ID: 12520089)
21. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Hernandez A; Thomas R; Smith F; Sandberg J; Kim S; Chung DH; Evers BM Surgery; 2001 Aug; 130(2):265-72. PubMed ID: 11490359 [TBL] [Abstract][Full Text] [Related]
22. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. Sharp DA; Lawrence DA; Ashkenazi A J Biol Chem; 2005 May; 280(19):19401-9. PubMed ID: 15760909 [TBL] [Abstract][Full Text] [Related]
24. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Thomas RP; Farrow BJ; Kim S; May MJ; Hellmich MR; Evers BM Surgery; 2002 Aug; 132(2):127-34. PubMed ID: 12219002 [TBL] [Abstract][Full Text] [Related]
25. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Hao C; Beguinot F; Condorelli G; Trencia A; Van Meir EG; Yong VW; Parney IF; Roa WH; Petruk KC Cancer Res; 2001 Feb; 61(3):1162-70. PubMed ID: 11221847 [TBL] [Abstract][Full Text] [Related]
26. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965 [TBL] [Abstract][Full Text] [Related]
27. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Song JH; Bellail A; Tse MC; Yong VW; Hao C J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480 [TBL] [Abstract][Full Text] [Related]
28. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D. Olsson A; Diaz T; Aguilar-Santelises M; Osterborg A; Celsing F; Jondal M; Osorio LM Leukemia; 2001 Dec; 15(12):1868-77. PubMed ID: 11753607 [TBL] [Abstract][Full Text] [Related]
29. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263 [TBL] [Abstract][Full Text] [Related]
30. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S; Meyer E; Debatin KM Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673 [TBL] [Abstract][Full Text] [Related]
31. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329 [TBL] [Abstract][Full Text] [Related]
32. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP; Zisman A; Bonavida B Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140 [TBL] [Abstract][Full Text] [Related]
33. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs. Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127 [TBL] [Abstract][Full Text] [Related]
34. High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells. Jönsson G; Paulie S; Grandien A Anticancer Res; 2003; 23(2B):1213-8. PubMed ID: 12820373 [TBL] [Abstract][Full Text] [Related]
35. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Kazhdan I; Marciniak RA Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201 [TBL] [Abstract][Full Text] [Related]
36. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL). Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254 [TBL] [Abstract][Full Text] [Related]
37. Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines. Kang J; Kisenge RR; Toyoda H; Tanaka S; Bu J; Azuma E; Komada Y Br J Haematol; 2003 Dec; 123(5):921-32. PubMed ID: 14632785 [TBL] [Abstract][Full Text] [Related]
38. Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells. Platzbecker U; Ward JL; Deeg HJ Br J Haematol; 2003 Aug; 122(3):489-97. PubMed ID: 12877678 [TBL] [Abstract][Full Text] [Related]
39. FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis. Dolcet X; Llobet D; Pallares J; Rue M; Comella JX; Matias-Guiu X Lab Invest; 2005 Jul; 85(7):885-94. PubMed ID: 15864316 [TBL] [Abstract][Full Text] [Related]
40. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Ramp U; Caliskan E; Mahotka C; Krieg A; Heikaus S; Gabbert HE; Gerharz CD Br J Cancer; 2003 Jun; 88(11):1800-7. PubMed ID: 12771998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]